Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NATCO PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NATCO PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    NATCO PHARMA
Mar-23
TEVA PHARMA
Dec-13
NATCO PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs8473,479-   
Low Rs5023,022-   
Sales per share (Unadj.) Rs148.41,996.4-  
Earnings per share (Unadj.) Rs39.2124.7-  
Cash flow per share (Unadj.) Rs48.2286.1-  
Dividends per share (Unadj.) Rs5.50109.18-  
Avg Dividend yield %0.83.4 24.3%  
Book value per share (Unadj.) Rs267.12,217.6-  
Shares outstanding (eoy) m182.47848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.51.6 279.2%   
Avg P/E ratio x17.226.1 66.0%  
P/CF ratio (eoy) x14.011.4 123.2%  
Price / Book Value ratio x2.51.5 172.3%  
Dividend payout %14.087.5 16.0%   
Avg Mkt Cap Rs m123,0492,756,220 4.5%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m4,8670-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m27,0711,692,969 1.6%  
Other income Rs m1,2850-   
Total revenues Rs m28,3561,692,969 1.7%   
Gross profit Rs m9,117463,620 2.0%  
Depreciation Rs m1,638136,844 1.2%   
Interest Rs m14533,253 0.4%   
Profit before tax Rs m8,619293,523 2.9%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m1,466-3,584 -40.9%   
Profit after tax Rs m7,153105,758 6.8%  
Gross profit margin %33.727.4 123.0%  
Effective tax rate %17.0-1.2 -1,393.2%   
Net profit margin %26.46.2 423.0%  
BALANCE SHEET DATA
Current assets Rs m30,0031,143,425 2.6%   
Current liabilities Rs m6,831997,163 0.7%   
Net working cap to sales %85.68.6 990.8%  
Current ratio x4.41.1 383.0%  
Inventory Days Days6391 69.9%  
Debtors Days Days11596 120.3%  
Net fixed assets Rs m26,571552,961 4.8%   
Share capital Rs m3654,167 8.8%   
"Free" reserves Rs m48,3730-   
Net worth Rs m48,7381,880,567 2.6%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m56,5743,868,976 1.5%  
Interest coverage x60.49.8 615.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 109.4%   
Return on assets %12.93.6 359.0%  
Return on equity %14.75.6 261.0%  
Return on capital %18.04.9 364.6%  
Exports to sales %00-   
Imports to sales %10.20-   
Net fx Rs m14,4840-   
CASH FLOW
From Operations Rs m8,491269,772 3.1%  
From Investments Rs m-4,771-95,591 5.0%  
From Financial Activity Rs m-3,630-323,609 1.1%  
Net Cashflow Rs m208-149,429 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare NATCO PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare NATCO PHARMA With: EMMESSAR CHM  BAFNA PHARMA  SEQUENT SCIENTIFIC  CHEMO PHARMA  SOURCE NATURAL FOODS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.